In a previous study, LDEVs inhibited cancer cell proliferation and suppress chronic myelocytic leukemia xenograft growth by inducing necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cell death [7]. Here, TNFSF10 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.